The Virtual Biopsy (TM) System enables the colonoscopist to determine whether tissue is normal, pre-cancerous or cancerous, without physically removing the tissue from the body.
It operates by using laser light to optically scan tissue and allows immediate tissue analysis.
The company's own clinical studies demonstrated a significant improvement in the endoscopists ability to correctly identify pre-cancerous or cancerous tissue.
The manufacturers claim that by providing a real time analysis, the physician will be able to diagnose and treat a patient in one procedure offering time and cost savings.
SpectraScience has also begun clinical investigations utilizing the same laser technology for detection of cancer in the esophagus and believes that in the future it may also be used for detecting cancers of other tissues such as the prostate, cervix and urinary bladder.